Redbubble Limited Raising Recommendation
|
|
- Brittney Osborne
- 5 years ago
- Views:
Transcription
1 Software and Services Australian Equity Research 26 October 2017 BUY from SPECULATIVE BUY PRICE TARGET unchanged Price (27-Oct) Ticker A$1.20 A$0.76 RBL-ASX 52-Week Range (A$): Market Cap (A$M): 157 Dividend /Shr (AUc): 0.0 Dividend Yield (%) : 0.0 Enterprise Value (A$M): 130 Cash (A$M): 27.8 Long-Term Debt (A$M): 0.0 FYE Jun 2017A 2018E 2019E 2020E Sales (A$M) Previous Gross Profit (A$M) EBITDA (A$M) (8.3) (1.7) Previous - (3.1) Net Income Adj (A$M) (7.7) (6.1) (2.0) 4.8 Previous - (7.2) (3.4) 4.3 EPS Adj&Dil (AUc) (3.76) (2.67) (0.86) 2.1 Previous - (3.15) (1.47) 1.9 Net Debt (Cash) (A$M) (28) (22) (18) (23) Previous - (21) (15) (20) Nov-16 Dec-16 RBL Jan-17 Source:FactSet Feb-17 Mar-17 Apr-17 Priced intraday 27 October 2017 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Owen Humphries Analyst Canaccord Genuity (Australia) Ltd. owen.humphries@canaccord.com.au Momentum into the peak Christmas period Redbubble (RBL) released its 1Q18a quarterly report illustrating strong momentum with the group on track to achieve its stated FY18 target of "top-line constant currency (cc) growth in line with FY17 (+30%)". RBL reported Gross Transaction Value (GTV) growth of +26% during 1Q18a that translated to an impressive +31% growth on a constant currency basis. The strong AUD was again a drag on growth (-5%), particularly against the USD, with 93% of RBL's revenues sourced offshore. Earnings revisions: FY18e, FY19e & FY20e gross profit increased +2%, +3% & +1%. Key points from the quarterly: RBL illustrated prudent cost control with opex (incl. paid acq. costs) increasing just +2.8% vs. 4Q17a (despite a higher sales period). Going forward management is targeting opex growth (incl. paid acq) to be half GTV growth. This approach will aid strong operating leverage with RBL "increasingly confident of meeting its previous guidance of moving into ongoing operating EBITDA profitability late in FY18". RBL generated positive OCF (+$3.2m) for the first time in 1Q and provides momentum into a strong cash collections period during Christmas (2Q >35% GTV cont.). RBL reported a cash balance of A$29m, and given the negative working capital cycle, we expect this balance to materially increase by Dec-17 (CGAu est. 1H18e cash >$40m). The balance sheet strength enables the group to invest in sustainable/long term growth as it approaches EBITDA breakeven in FY18e. RBL's 1Q18a constant currency revenue growth (+26%) slightly lagged GTV growth (+31%) due to a) timing differences between ordering/shipping in a busy Sept-17 and b) slightly larger sales tax component following RBL's successful entrance into various European markets (Spain, Germany, France). RBL's gross profit margin slightly dipped in 1Q18a (35.6% vs. 36.4% in the pcp) following product mix/price reductions, however was equivalent to FY17a (FY %). In previous periods RBL has been successful in extracting better margins from its manufacturers/fulfillers, and we expect further reductions in 2Q18e. The Average Order Value (AOV) reduced -7.9% vs. pcp (A$43.6), with the major driver the strong AUD (-5%). We expect this to be partially reversed as the AUD moderates into the peak 2Q. RBL continues to be impacted by the rapid shift to mobile (50%/24% mobile/desktop traffic growth) which derives a larger proportion of traffic through paid sources and a lower customer conversion rate (mobile 1.3%, desktop 2.6%). This resulted in a modest uplift to RBL's CAC during the period. RBL financials mimic those of other global high growth marketplaces, with a capital light balance sheet and strong revenue growth. We view RBL as fundamentally undervalued trading at 2.1x FY19e EV/gross profit as the company approaches breakeven with a strong revenue growth profile (FY18e >25%, 5yr CAGR +51%). In our view, achieving EBITDA breakeven in 4Q18e will be a key milestone and likely improve investor sentiment to the stock as it generates profitable growth. Following management's increased confidence in achieving breakeven, we upgrade to a BUY recommendation (prev. SPEC. BUY) and maintain our price target of $1.20ps. Canaccord Genuity is the global capital markets group of Canaccord Genuity Group Inc. (CF : TSX) The recommendations and opinions expressed in this research report accurately reflect the research analyst's personal, independent and objective views about any and all the companies and securities that are the subject of this report discussed herein. For important information, please see the Important Disclosures beginning on page 7 of this document.
2 Figure 1: CGAu RBL forecasts RedBubble Limited $ 0.76 Profit & Loss ($m) - Jun YE 2016A 2017A 2018F 2019F 2020F Valuation ratios 2016A 2017A 2018F 2019F 2020F Gross Transaction Value EPS (cps) Sales Revenue EPS Growth (%) nmf nmf nmf nmf nmf Gross Profit Enterprise Value ($m) - pro-forma Cust. Acq costs EV/Revenue Gross Profit (post CAC) EV/Gross Profit Admin/mkting EV / Sustainable EBITDA (x) Salaries EBITDA EV/GPV EBITDA - excl. growth opex P/E (x) D & A EV / Statutory EBITDA (x) EBIT EV / EBIT (x) Net Interest Expense FCF yield (%) -3.5% -3.9% 2.0% 3.1% 7.3% NPBT DPS (cps) Tax expense NPAT (Normalised) Balance Sheet ratios 2016A 2017A 2018F 2019F 2020F Non-recurring Net Debt (cash) NPAT (Reported) NTA per share ($) Price / NTA (x) Gross Profit Margin (%) 34.0% 35.5% 35.0% 34.0% 34.0% Shares on issue EBITDA Margin % (excl. growth opex) 10.7% 13.3% 15.9% 17.2% 19.3% EFPOWA (m) Statutory EBITDA Margin (%) -7.2% -5.9% -1.0% 1.8% 4.9% EBIT Margin (%) -10.7% -10.5% -4.9% -1.4% 2.2% Interim Analysis 2H16A 1H17A 2H17A 1H18E 2H18E NPAT Margin (%) -15.1% -5.4% -3.5% -0.9% 1.8% GTV Revenues Cash Flow ($m) - Jun YE 2016A 2017A 2018F 2019F 2020F Gross Profit Operating EBITDA EBIT Interest & Tax Paid EBIT margin (%) -12.7% -5.3% -17.1% 22.5% -41.2% +/- change in Work. Cap DPS other Operating Cashflow Assumptions 2016A 2017A 2018F 2019F 2020F - Capex (PPE) CAC Capex (Intangibles) Avg Order Value Aquisitions/divestments % New GTV 65% 62% 58% 58% 58% Free Cashflow Conversion rate 1.9% 2.0% 2.1% 2.0% 2.0% - Ord Dividends GTV Growth 62% 23% 24% 23% 23% - Equity /other Revenue Growth 61% 23% 25% 23% 23% Net Cashflow GP Margins 34.0% 35.5% 35.0% 34.0% 34.0% Cash at beginning of period Operating Expenses growth 53% 17% 3% 3% 3% +/- borrowings / other Take-rate (GP/GTV) 27.3% 28.6% 28.4% 27.5% 27.5% Cash at end of period Board of Directors/Substantial shareholders Balance Sheet - Jun YE 2016A 2017A 2018F 2019F 2020F Board of Directors Shareholding % Cash Richard Cawsey % Debtors Grant Murdoch 0.1 0% PPE Gregory Lockwood (Piton Capital) 6.5 3% Intangibles Stephanie Tilenius 0.0 0% Other assets Teresa Engelhard 0.0 0% Total Assets Martin Hosking % Borrowings Trade Creditors Substantial shareholders Shareholding % Other Liabilities Blackbird % Total Liabilities Acorn % NET ASSETS Osmium Partners % Source: Company Reports, Canaccord Genuity estimates Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 2
3 Figure 2: Consistent growth in GTV in recent years A$m RBL Quarterly GTV (A$m) % 120% % 80% 60% 40% 20% 108% 82% 78% 46% RBL Quarterly GTV growth (%) 18% 47% 56% 73% 99% 71% 47% 40% Appreciating AUD impacting GTV growth 25% 26% 26% 21% 20% 0.0 0% 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 Source: Company Reports, Canaccord Genuity estimates Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 3
4 Figure 3: P&L modeling assumption Model Assumptions FY14A 1H15E 2H15E FY15A 1H16A 2H16A FY16A 1H17A 2H17A FY17A FY18E FY19E FY20E FY21E FY22E FY23E GTV A$m Repeat GTV A$m % Repeat % % 34.2% 32.6% 33.9% 37.6% 35.5% 37.3% 38.8% 38.0% 42.5% 42.0% 42.0% 42.0% 42.0% 42.0% New GTV A$m % New % 73.0% 69.0% 65.8% 67.4% 66.1% 62.4% 64.5% 62.7% 61.2% 62.0% 57.5% 58.0% 58.0% 58.0% 58.0% 58.0% Visits m Conversion Rate % 1.2% 1.9% 1.6% 1.8% 2.0% 1.7% 1.9% 2.2% 1.7% 2.0% 2.1% 2.0% 2.0% 2.0% 2.0% 2.0% AOV (A$) A$ Growth % 0.2% 7.7% 6.0% 7.3% -8.3% -10.4% -9.6% -3% -1% -1% 0% 0% 0% GP/Order A$ Total Cust. Orders m New Cust. Orders m Acq. costs A$m New order/cust. (CAC) $/orde CAC inflation % 35% 19% 24% 34% 28% 7% 4% 5% 3% 3% 3% P&L Breakdown FY14A 1H15 2H15 FY15A 1H16A 2H16A FY16A 1H17A 2H17A FY17A FY18E FY19E FY20E FY21E FY22E FY23E Revenue and Gross Profit forecasts Total GTV A$m Growth % 76% 49% 79% 44% 62% 23% 23% 23% 24% 23% 23% 17% 17% 17% Redbubble Revenue A$m Revenue take-rate % 82.0% 81.2% 79.7% 80.4% 77.6% 83.5% 80.2% 79.8% 81.1% 80.4% 81.0% 81.0% 81.0% 81.0% 81.0% 81.0% Growth 76.7% 46.3% 71.3% 50.5% 61.2% 26.3% 19.2% 23.1% 24.8% 22.7% 22.6% 16.5% 16.5% 16.5% Effective Take rate % 34.0% 34.7% 33.1% 33.9% 32.9% 35.4% 34.0% 36.0% 35.0% 35.5% 35.0% 34.0% 34.0% 34.0% 34.0% 34.0% Gross Profit A$m Growth % 74% 46% 62% 61% 62% 38% 18% 28% 23% 19% 23% 17% 17% 17% Expense Breakdown Paid Acq. costs A$m Growth % 85% 68% 97% 80% 56% 65% 60% 30% 30% 30% 20% 20% 20% Gross Profit (after paid acq costs) A$m Admin. Costs A$m Growth % 104% 51% 40% 45% 18% 5% 9% 3% 3% 3% 4% 4% 4% Employee/contractor costs A$m Growth % 123% 174% 21% 67% 20% 2% 20% 5% 3% 3% 3% 3% 3% Marketing (other) costs A$m Growth % -6% -18% 3% 3% 0% 0% 0% 0% Operating Expenses A$m Growth Opex A$m EBITDA (pre-growth) A$m Maintenance opex** A$m EBITDA (normal) A$m Depreciaiton & Amortisation A$m EBIT A$m Interest A$m NPBT A$m Tax (@25%) A$m NPAT (normalised) A$m Non-recurring A$m NPAT (reported) A$m **CGAu est. for previous years Source: Company Reports, Canaccord Genuity estimates Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 4
5 Figure 4: RBL key growth initiatives Source: Company Reports, Canaccord Genuity Figure 5: CGAu DCF valuation DCF Valuation FY18 FY19 FY20 FY21 FY22 FY23 Terminal Value Look-through valuation Sustainable EBITDA A$m Capex A$m Look-through EBITDA (post capex) A$m Discount factor x Valuation A$m Growth opex valuation Growth cost A$m Discount factor x Valuation A$m Tax, Interest Exp. & ΔW.C Discount factor x Valuation A$m Enterprise Value A$m Risk Free Rate % 2.8% Net Cash/(Debt) A$m 27.8 Equity RP % 5.5% Equity Valuation A$m Beta x 2.2 EFPOWA # Cost of Equity % 15% Valuation (today) $ps 1.04 Debt proportion % 0.0% Cost of Equity % 15% Terminal growth rate % 2.0% Valuation (1 yr forward) cps 1.20 Source: Company Reports, Canaccord Genuity estimates Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 5
6 Figure 6: RBL peer group and multiple expansion opportunity Enterprise Revenue Gross Profit EV/Revenue EV/Gross Profit Revenue Growth Company Ticker Price Currency Market Cap Value FY16 FY17 FY18 FY19 FY16 FY17 FY18 FY15 FY16 FY17 FY18 FY15 FY16 FY17 FY18 FY16 FY17 FY18 FY19 Freelancer FLN $0.59 AUD $271 $ % -1% 9% 14% Etsy ETSY $15.81 USD $1,870 $1, % 20% 18% 17% Shutterstock SSTK $34.60 USD $1,198 $ % 8% 10% 9% Shutterfly SFLY $44.20 USD $1,450 $1,760 1,157 1,152 1,213 1, % 0% 5% 6% Stamps.com Inc STMP $ USD $3,887 $3, % 28% 17% ASOS AIM:ASC $56.10 GBP $4,599 $4,439 1,437 1,935 2,466 2, , % 35% 27% 21% Boohoo.com AIM:BOO $1.97 GBP $2,261 $2, % 55% 84% 36% YOOX Net-a-Porter BIT:YNAP $32.74 EUR $4,389 $4,335 1,875 2,137 2,501 2, % 14% 17% 19% Webjet ASX:WEB $11.82 AUD $1,397 $1, % 51% 29% 20% Seek SEK $18.34 AUD $6,399 $6, ,018 1,249 1, , % 4% 23% 11% REA Group REA $71.49 AUD $9,416 $9, % 7% 18% 13% Carsales.com.au ASX:CAR $13.85 AUD $3,359 $3, % 7% 10% 8% Redbubble RBL $0.76 AUD $172 $ % 25% 22% 23% Average (excl. RB) her high growth global marketplaces Facebook FB $ USD $495,456 $460,004 27,352 39,238 51,066 63,697 22,428 32,175 41, % 43% 30% 25% Twitter TWTR $17.14 USD $12,588 $10,254 2,554 2,401 2,548 2,733 1,788 1,680 1, % -6% 6% 7% Netflix NFLX $ USD $83,850 $86,993 8,751 11,048 14,905 17,949 2,800 3,535 4, % 26% 35% 20% Amazon AMZN $ USD $467,366 $469, , , , ,277 39,727 50,659 64, % 28% 28% 19% VIP Shop VIPS $7.97 USD $4,683 $4,746 56,036 71,763 85,932 98,449 14,009 17,941 21, % 28% 20% 15% Alibaba Group (USD) BABA $ USD $430,548 $371,252 15,360 21,623 35,709 47,770 10,752 15,136 24, % 41% 65% 34% ebay EBay $36.68 USD $38,315 $42,283 8,984 9,565 10,250 10,906 7,097 7,556 8, % 6% 7% 6% Leaf Group LFGR $7.00 USD $141 $ % 10% 12% 15% Wayfair W $64.52 USD $5,625 $5,451 3,367 4,621 5,932 7, ,109 1, % 37% 28% 26% Grubhub GRUB $57.79 USD $4,993 $4, , % 38% 29% 24% Average (excl. RB) Source: Company Reports, Canaccord Genuity, CapitalIQ consensus estimates FY18 EV/Gross Profit (x) EV/Gross Profit (FY18) REA Group x 20.0 Webjet 18.0 Carsales.com.au Facebook Stamps.com Grubhub Average 7.6x Amazon 8.0 Etsy Twitter Seek ebay Redbubble 2.4x Wayfair Freelancer.com 4.0 ASOS YOOX Shutterfly Leaf Group Shutterstock Redbubble 0.0 0% 5% 10% 15% 20% 25% 30% 35% Revenue Growth (2yr CAGR, FY18-FY19) Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 6
7 Appendix: Important Disclosures Analyst Certification Each authoring analyst of Canaccord Genuity whose name appears on the front page of this research hereby certifies that (i) the recommendations and opinions expressed in this research accurately reflect the authoring analyst s personal, independent and objective views about any and all of the designated investments or relevant issuers discussed herein that are within such authoring analyst s coverage universe and (ii) no part of the authoring analyst s compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by the authoring analyst in the research. Analysts employed outside the US are not registered as research analysts with FINRA. These analysts may not be associated persons of Canaccord Genuity Inc. and therefore may not be subject to the FINRA Rule 2241 and NYSE Rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account. Sector Coverage Individuals identified as Sector Coverage cover a subject company s industry in the identified jurisdiction, but are not authoring analysts of the report. Investment Recommendation Date and time of first dissemination: October 26, 2017, 20:56 ET Date and time of production: October 26, 2017, 20:56 ET Target Price / Valuation Methodology: - RBL Our price target of $1.20ps has been derived using a DCF methodology. Risks to achieving Target Price / Valuation: - RBL Attracting and retaining independent artists; attracting and converting customers; a shift in customer trend; and action of competitors or substitute offerings. Distribution of Ratings: Global Stock Ratings (as of 10/26/17) Rating Coverage Universe IB Clients # % % Buy % 39.79% Hold % 23.51% Sell % 17.39% Speculative Buy % 68.89% 927* 100.0% *Total includes stocks that are Under Review Canaccord Genuity Ratings System BUY: The stock is expected to generate risk-adjusted returns of over 10% during the next 12 months. HOLD: The stock is expected to generate risk-adjusted returns of 0-10% during the next 12 months. SELL: The stock is expected to generate negative risk-adjusted returns during the next 12 months. NOT RATED: Canaccord Genuity does not provide research coverage of the relevant issuer. Risk-adjusted return refers to the expected return in relation to the amount of risk associated with the designated investment or the relevant issuer. Risk Qualifier SPECULATIVE: Stocks bear significantly higher risk that typically cannot be valued by normal fundamental criteria. Investments in the stock may result in material loss. 12-Month Recommendation History (as of date same as the Global Stock Ratings table) A list of all the recommendations on any issuer under coverage that was disseminated during the preceding 12-month period may be obtained at the following website (provided as a hyperlink if this report is being read electronically) Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 7
8 Required Company-Specific Disclosures (as of date of this publication) currently is, or in the past 12 months was, a client of Canaccord Genuity or its affiliated companies. During this period, Canaccord Genuity or its affiliated companies provided investment banking services to. In the past 12 months, Canaccord Genuity or its affiliated companies have received compensation for Investment Banking services from. In the past 12 months, Canaccord Genuity or any of its affiliated companies have been lead manager, co-lead manager or co-manager of a public offering of securities of or any publicly disclosed offer of securities of or in any related derivatives. Canaccord Genuity or one or more of its affiliated companies intend to seek or expect to receive compensation for Investment Banking services from in the next three months. The primary analyst, a member of primary analyst's household, or any individual directly involved in the preparation of this research, has a long position in the shares or derivatives, or has any other financial interest in, the value of which increases as the value of the underlying equity increases. I:B:AUD2.59 B:AUD /30/16 08/02/16 AUD3.00 AUD2.50 AUD2.00 AUD1.50 AUD1.00 B:AUD /25/16 B:AUD /30/17 H:AUD /26/17 Rating History as of 10/24/2017 H:AUD /24/17 SB:AUD /27/17 AUD0.50 Jan 15 Apr 15 Jul 15 Oct 15 Jan 16 Apr 16 Jul 16 Oct 16 Jan 17 Apr 17 Jul 17 Oct 17 Closing Price Target Price Buy (B); Speculative Buy (SB); Sell (S); Hold (H); Suspended (SU); Under Review (UR); Restricted (RE); Not Rated (NR) Online Disclosures Up-to-date disclosures may be obtained at the following website (provided as a hyperlink if this report is being read electronically) or by sending a request to Canaccord Genuity Corp. Research, Attn: Disclosures, P.O. Box Pacific Centre, Granville Street, Vancouver, BC, Canada V7Y 1H2; or by sending a request by to disclosures@canaccordgenuity.com. The reader may also obtain a copy of Canaccord Genuity s policies and procedures regarding the dissemination of research by following the steps outlined above. General Disclaimers See Required Company-Specific Disclosures above for any of the following disclosures required as to companies referred to in this report: manager or co-manager roles; 1% or other ownership; compensation for certain services; types of client relationships; research analyst conflicts; managed/co-managed public offerings in prior periods; directorships; market making in equity securities and related derivatives. For reports identified above as compendium reports, the foregoing required company-specific disclosures can be found in a hyperlink located in the section labeled, Compendium Reports. Canaccord Genuity is the business name used by certain wholly owned subsidiaries of Canaccord Genuity Group Inc., including Canaccord Genuity Inc., Canaccord Genuity Limited, Canaccord Genuity Corp., and Canaccord Genuity (Australia) Limited, an affiliated company that is 50%-owned by Canaccord Genuity Group Inc. The authoring analysts who are responsible for the preparation of this research are employed by Canaccord Genuity Corp. a Canadian broker-dealer with principal offices located in Vancouver, Calgary, Toronto, Montreal, or Canaccord Genuity Inc., a US broker-dealer with principal offices located in New York, Boston, San Francisco and Houston, or Canaccord Genuity Limited., a UK broker-dealer with principal offices located in London (UK) and Dublin (Ireland), or Canaccord Genuity (Australia) Limited, an Australian broker-dealer with principal offices located in Sydney and Melbourne. The authoring analysts who are responsible for the preparation of this research have received (or will receive) compensation based upon (among other factors) the Investment Banking revenues and general profits of Canaccord Genuity. However, such authoring analysts have not received, and will not receive, compensation that is directly based upon or linked to one or more specific Investment Banking activities, or to recommendations contained in the research. Some regulators require that a firm must establish, implement and make available a policy for managing conflicts of interest arising as a result of publication or distribution of research. This research has been prepared in accordance with Canaccord Genuity s policy on Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 8
9 managing conflicts of interest, and information barriers or firewalls have been used where appropriate. Canaccord Genuity s policy is available upon request. The information contained in this research has been compiled by Canaccord Genuity from sources believed to be reliable, but (with the exception of the information about Canaccord Genuity) no representation or warranty, express or implied, is made by Canaccord Genuity, its affiliated companies or any other person as to its fairness, accuracy, completeness or correctness. Canaccord Genuity has not independently verified the facts, assumptions, and estimates contained herein. All estimates, opinions and other information contained in this research constitute Canaccord Genuity s judgement as of the date of this research, are subject to change without notice and are provided in good faith but without legal responsibility or liability. From time to time, Canaccord Genuity salespeople, traders, and other professionals provide oral or written market commentary or trading strategies to our clients and our principal trading desk that reflect opinions that are contrary to the opinions expressed in this research. Canaccord Genuity s affiliates, principal trading desk, and investing businesses also from time to time make investment decisions that are inconsistent with the recommendations or views expressed in this research. This research is provided for information purposes only and does not constitute an offer or solicitation to buy or sell any designated investments discussed herein in any jurisdiction where such offer or solicitation would be prohibited. As a result, the designated investments discussed in this research may not be eligible for sale in some jurisdictions. This research is not, and under no circumstances should be construed as, a solicitation to act as a securities broker or dealer in any jurisdiction by any person or company that is not legally permitted to carry on the business of a securities broker or dealer in that jurisdiction. This material is prepared for general circulation to clients and does not have regard to the investment objectives, financial situation or particular needs of any particular person. Investors should obtain advice based on their own individual circumstances before making an investment decision. To the fullest extent permitted by law, none of Canaccord Genuity, its affiliated companies or any other person accepts any liability whatsoever for any direct or consequential loss arising from or relating to any use of the information contained in this research. Research Distribution Policy Canaccord Genuity research is posted on the Canaccord Genuity Research Portal and will be available simultaneously for access by all of Canaccord Genuity s customers who are entitled to receive the firm's research. In addition research may be distributed by the firm s sales and trading personnel via , instant message or other electronic means. Customers entitled to receive research may also receive it via third party vendors. Until such time as research is made available to Canaccord Genuity s customers as described above, Authoring Analysts will not discuss the contents of their research with Sales and Trading or Investment Banking employees without prior compliance consent. For further information about the proprietary model(s) associated with the covered issuer(s) in this research report, clients should contact their local sales representative. Short-Term Trade Ideas Research Analysts may, from time to time, discuss short-term trade ideas in research reports. A short-term trade idea offers a nearterm view on how a security may trade, based on market and trading events or catalysts, and the resulting trading opportunity that may be available. Any such trading strategies are distinct from and do not affect the analysts' fundamental equity rating for such stocks. A short-term trade idea may differ from the price targets and recommendations in our published research reports that reflect the research analyst's views of the longer-term (i.e. one-year or greater) prospects of the subject company, as a result of the differing time horizons, methodologies and/or other factors. It is possible, for example, that a subject company's common equity that is considered a longterm Hold' or 'Sell' might present a short-term buying opportunity as a result of temporary selling pressure in the market or for other reasons described in the research report; conversely, a subject company's stock rated a long-term 'Buy' or Speculative Buy could be considered susceptible to a downward price correction, or other factors may exist that lead the research analyst to suggest a sale over the short-term. Short-term trade ideas are not ratings, nor are they part of any ratings system, and the firm does not intend, and does not undertake any obligation, to maintain or update short-term trade ideas. Short-term trade ideas are not suitable for all investors and are not tailored to individual investor circumstances and objectives, and investors should make their own independent decisions regarding any securities or strategies discussed herein. Please contact your salesperson for more information regarding Canaccord Genuity s research. For Canadian Residents: This research has been approved by Canaccord Genuity Corp., which accepts sole responsibility for this research and its dissemination in Canada. Canaccord Genuity Corp. is registered and regulated by the Investment Industry Regulatory Organization of Canada (IIROC) and is a Member of the Canadian Investor Protection Fund. Canadian clients wishing to effect transactions in any designated investment discussed should do so through a qualified salesperson of Canaccord Genuity Corp. in their particular province or territory. For United States Persons: Canaccord Genuity Inc., a US registered broker-dealer, accepts responsibility for this research and its dissemination in the United States. This research is intended for distribution in the United States only to certain US institutional investors. US clients wishing to effect transactions in any designated investment discussed should do so through a qualified salesperson of Canaccord Genuity Inc. Analysts employed outside the US, as specifically indicated elsewhere in this report, are not registered as research analysts with FINRA. These analysts may not be associated persons of Canaccord Genuity Inc. and therefore may not be subject to the FINRA Rule 2241 and NYSE Rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account. Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 9
10 For United Kingdom and European Residents: This research is distributed in the United Kingdom and elsewhere Europe, as third party research by Canaccord Genuity Limited, which is authorized and regulated by the Financial Conduct Authority. This research is for distribution only to persons who are Eligible Counterparties or Professional Clients only and is exempt from the general restrictions in section 21 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to engage in investment activity on the grounds that it is being distributed in the United Kingdom only to persons of a kind described in Article 19(5) (Investment Professionals) and 49(2) (High Net Worth companies, unincorporated associations etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended). It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. This material is not for distribution in the United Kingdom or elsewhere in Europe to retail clients, as defined under the rules of the Financial Conduct Authority. For Jersey, Guernsey and Isle of Man Residents: This research is sent to you by Canaccord Genuity Wealth (International) Limited (CGWI) for information purposes and is not to be construed as a solicitation or an offer to purchase or sell investments or related financial instruments. This research has been produced by an affiliate of CGWI for circulation to its institutional clients and also CGWI. Its contents have been approved by CGWI and we are providing it to you on the basis that we believe it to be of interest to you. This statement should be read in conjunction with your client agreement, CGWI's current terms of business and the other disclosures and disclaimers contained within this research. If you are in any doubt, you should consult your financial adviser. CGWI is licensed and regulated by the Guernsey Financial Services Commission, the Jersey Financial Services Commission and the Isle of Man Financial Supervision Commission. CGWI is registered in Guernsey and is a wholly owned subsidiary of Canaccord Genuity Group Inc. For Australian Residents: This research is distributed in Australia by Canaccord Genuity (Australia) Limited ABN holder of AFS Licence No To the extent that this research contains any advice, this is limited to general advice only. Recipients should take into account their own personal circumstances before making an investment decision. Clients wishing to effect any transactions in any financial products discussed in the research should do so through a qualified representative of Canaccord Genuity (Australia) Limited. Canaccord Genuity Wealth Management is a division of Canaccord Genuity (Australia) Limited. For Hong Kong Residents: This research is distributed in Hong Kong by Canaccord Genuity (Hong Kong) Limited which is licensed by the Securities and Futures Commission. This research is only intended for persons who fall within the definition of professional investor as defined in the Securities and Futures Ordinance. It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. Recipients of this report can contact Canaccord Genuity (Hong Kong) Limited. (Contact Tel: ) in respect of any matters arising from, or in connection with, this research. Additional information is available on request. Copyright Canaccord Genuity Corp Member IIROC/Canadian Investor Protection Fund Copyright Canaccord Genuity Limited Member LSE, authorized and regulated by the Financial Conduct Authority. Copyright Canaccord Genuity Inc Member FINRA/SIPC Copyright Canaccord Genuity (Australia) Limited Participant of ASX Group, Chi-x Australia and of the NSX. Authorized and regulated by ASIC. All rights reserved. All material presented in this document, unless specifically indicated otherwise, is under copyright to Canaccord Genuity Corp., Canaccord Genuity Limited, Canaccord Genuity Inc or Canaccord Genuity Group Inc. None of the material, nor its content, nor any copy of it, may be altered in any way, or transmitted to or distributed to any other party, without the prior express written permission of the entities listed above. None of the material, nor its content, nor any copy of it, may be altered in any way, reproduced, or distributed to any other party including by way of any form of social media, without the prior express written permission of the entities listed above. Buy from Speculative Buy Target Price A$1.20 unchanged 26 October 2017 Software and Services 10
Redbubble Limited. Software and Services. Estimates Revised
Software and Services Australian Equity Research 25 April 2018 Owen Humphries Analyst Canaccord Genuity (Australia) Ltd. owen.humphries@canaccord.com.au +61.2.9263.2702 BUY unchanged PRICE TARGET unchanged
More informationRedbubble Limited. Jaws beginning to open
Software and Services Australian Equity Research 24 October 2016 BUY unchanged PRICE TARGET unchanged Price (24-Oct) Ticker A$2.52 A$0.96 RBL-ASX 52-Week Range (A$): 0.92-1.46 Market Cap (A$M): 190 Dividend
More informationOsprey Medical Inc. Struggling to take off
Biotechnology Australian Equity Research 26 April 2018 HOLD unchanged PRICE TARGET from A$0.45 Price (26-Apr) Ticker A$0.20 A$0.17 OSP-ASX 52-Week Range (A$): 0.21-0.51 Avg Daily Vol (000s) : 179.0 Market
More informationNanosonics Limited. Strong start to FY16
Biomedical Devices and Services Australian Equity Research 30 October 2015 BUY unchanged PRICE TARGET unchanged Price (30-Oct) Ticker A$1.95 A$1.64 NAN-ASX 52-Week Range (A$): 0.94-2.02 Avg Daily Vol (000s)
More informationFreelancer Limited. Software and Services. Raising Target Price
Software and Services Australian Equity Research 30 July 2015 BUY unchanged PRICE TARGET from A$1.46 Price (27-Jul) Ticker A$1.75 A$1.35 FLN-ASX 52-Week Range (A$): 0.52-1.74 Market Cap (A$M): 603 Dividend
More informationCodan Limited. Detecting another upgrade
Communications Equipment Australian Equity Research 17 May 2017 HOLD unchanged PRICE TARGET from A$2.36 Price (17-May) Ticker A$2.50 A$2.35 CDA-ASX 52-Week Range (A$): 0.53-1.65 Avg Daily Vol (000s) :
More informationGalilee Energy. Patience required
Oil and Gas, Exploration and Production James Bullen Analyst Canaccord Genuity (Australia) Ltd. james.bullen@canaccord.com.au +61.2.9263.2728 31 January 2019 SPECULATIVE BUY unchanged PRICE TARGET from
More informationCodan Limited. It's all about the base!
Communications Equipment Australian Equity Research 22 February 2018 BUY unchanged PRICE TARGET from A$2.60 Price (22-Feb) Ticker A$3.00 A$2.34 CDA-ASX 52-Week Range (A$): 1.86-2.56 Avg Daily Vol (000s)
More informationAUS Update 1 7 April Centaurus Metals Limited. BUY Target: A$0.55 CTM: ASX
Centaurus Metals Limited CTM: ASX BUY Target: A$0.55 AUS Update 1 Luke Smith +61.3.8688.9136 luke.smith@canaccord.com.au COMPANY STATISTICS: Share Price (A$) $0.13 12 Month Range $0.10 - $0.25 Market Cap
More informationGalaxy Resources Limited. JunQ report
Specialty Minerals and Metals Australian Equity Research 17 July 2017 BUY unchanged PRICE TARGET unchanged Price (17-Jul) Ticker A$3.50 A$1.84 GXY-ASX 52-Week Range (A$): 1.43-3.48 Avg Daily Vol (M) :
More informationMetals X Limited. FY18 results
Base Metals - Producer Australian Equity Research 3 September 2018 BUY unchanged PRICE TARGET from A$1.10 Price (3-Sep) Ticker A$1.00 A$0.52 MLX-ASX 52-Week Range (A$): 0.50-1.23 Avg Daily Vol (M) : 2.9
More informationSPECULATIVE BUY Target: C$1.40. Event. Impact. Action
Daily Letter 1 Intrinsyc Software International Inc. ICS : TSX : C$0.49 SPECULATIVE BUY Target: C$1.40 Peter Misek, CA, CPA, CFA 1.416.869.7920 peter.misek@canaccordadams.com Dushan Batrovic, MBA 1.416.869.7399
More informationGalaxy Resources Limited
Specialty Minerals and Metals Australian Equity Research 8 March 2016 Reg Spencer Analyst Canaccord Genuity (Australia) Ltd. reg.spencer@canaccord.com.au +61.2.9263.2701 Tim McCormack Analyst Canaccord
More informationDacian Gold Limited. Capital raising to fund DFS
Precious Metals - Developer/Explorer Australian Equity Research 9 November 2015 SPECULATIVE BUY unchanged PRICE TARGET unchanged Price (9-Nov) Ticker A$1.25 A$0.72 DCN-ASX 52-Week Range (A$): 0.24-0.94
More informationDacian Gold Limited. All go at Mount Morgans
Precious Metals - Developer/Explorer Australian Equity Research 22 May 2017 SPECULATIVE BUY unchanged PRICE TARGET from A$3.40 Price (19-May) Ticker A$3.35 A$1.79 DCN-ASX 52-Week Range (A$): 1.50-3.88
More informationCentaurus Metals Limited
AUS Update 1 Centaurus Metals Limited ASX : CTM BUY Target: $0.73 Luke Smith +61 3 8688 9136 luke.smith@canaccord.com.au COMPANY STATISTICS: Share Price $0.15 12 Month Range $0.15 - $0.74 Market Cap $29m
More informationFluence Corporation. Fluence Quarterly report and updated guidance. Short term revenue delay - Long term growth appeal remains.
A research initiative by Canaccord Genuity Fluence Corporation Fluence Quarterly report and updated guidance Key Facts Company Code FLC Closing Price (31/1/18) $0.50 Date of Report 1/02/18 Company Website
More informationQBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision
AUSTRALIA QBE AU Price (at 10:44, 27 Apr 2016 GMT) Neutral A$11.19 Valuation A$ - DCF (WACC 9.3%, beta 1.1, ERP 5.0%, RFR 3.8%) 11.34 12-month target A$ 12.00 12-month TSR % +12.7 Volatility Index Low/Medium
More informationVIX to Fall; Stocks to Rise; Small to Outperform
RBC Capital Markets, LLC October 14, 2014 VIX to Fall; Stocks to Rise; Small to Outperform Market Delivers Above-Average Returns Following Volatility Spikes Investor concerns regarding global growth have
More informationGenex Power (ASX:GNX)
A research initiative by Canaccord Genuity Genex Power (ASX:GNX) Excellent progress for Kidston green energy hub in North QLD Key Facts Company Code Share Price Performance 0.30 0.25 0.20 0.15 0.10 0.05
More informationSG Fleet Group. Another UK acquisition. Earnings and target price revision
AUSTRALIA SGF AU Price (at 08:26, 30 Nov 2016 GMT) Outperform A$3.23 Valuation - PER A$ 3.96-4.22 12-month target A$ 4.37 12-month TSR % +41.0 Volatility Index High GICS sector Commercial & Professional
More informationNIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst
AUSTRALIA NHF AU Price (at 09:52, 02 Mar 2016 GMT) Outperform A$3.72 Valuation A$ 3.85 - DCF (WACC 8.5%, beta 1.0, ERP 5.0%, RFR 3.8%, TGR 2.5%) 12-month target A$ 4.00 12-month TSR % +11.7 Volatility
More informationIOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.
AUSTRALIA IFL AU Price (at 06:35, 26 Oct 2016 GMT) Outperform A$8.34 Valuation A$ - DCF (WACC 8.8%, beta 1.1, ERP 5.0%, RFR 3.3%) 8.74 12-month target A$ 9.00 12-month TSR % +14.3 Volatility Index Low/Medium
More informationPlatinum Asset Management
AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium
More informationSilver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA SIV AU Price (at 08:50, 21 Mar 2017 GMT) Neutral A$7.71 Valuation - PER A$ 6.68 12-month target A$ 6.68 12-month TSR % -7.4 Volatility Index Medium GICS sector Capital Goods Market cap A$m 278
More informationCardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA CDD AU Price (at 04:53, 17 Feb 2015 GMT) Neutral A$2.88 Valuation - Sum of Parts A$ 2.80-3.43 12-month target A$ 3.12 12-month TSR % +18.4 Volatility Index Medium GICS sector Capital Goods Market
More informationSG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.
AUSTRALIA SGF AU Price (at 07:57, 27 Oct 2016 GMT) Outperform A$3.85 Valuation - PER A$ 3.92-4.18 12-month target A$ 4.37 12-month TSR % +18.1 Volatility Index Medium GICS sector Commercial & Professional
More informationCanadian Equity Strategy
INVESTMENT STRATEGY I RESEARCH Canadian Equity Strategy The U.S. Election Oct-16 RBC Dominion Securities Inc. Matthew Barasch (Chief Canadian Equity Strategist) (416) 842-7857 matt.barasch@rbccm.com This
More informationDemand for sovereign bonds: The importance of diversity
Demand for sovereign bonds: The importance of diversity ECB Bond Market Contact Group 1 July 2014 Christoph Rieger, Head of Interest Rate and Credit Research, +49 69 136 87664 Key themes (1) Core: Investor
More informationBoart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation
AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index
More informationVista Group International
NEW ZEALAND VGL NZ Price (at 03:15, 26 Feb 2015 GMT) Outperform NZ$4.35 Valuation NZ$ 4.31 - DCF (WACC 9.9%, beta 1.0, ERP 7.0%, RFR 4.0%, TGR 2.0%) 12-month target NZ$ 4.75 12-month TSR % +9.5 Volatility
More informationFIRST GLANCE COMMENT. Enbridge Inc. (TSX: ENB; 36.69; NYSE: ENB) Q1/07 Results Generally In Line. Sector Perform Average Risk. Impact Neutral.
125 WEEKS 17DEC04-01MAY07 Rel. S&P/TSX COMPOSITE INDEX HI-20MAY05 110.97 110.00 HI/LO DIFF -24.90% 100.00 90.00 40.00 38.00 36.00 34.00 32.00 30.00 28.00 7500 6000 4500 3000 1500 2005 D J F M A M J J A
More informationSeek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA SEK AU Price (at 06:33, 07 Apr 2017 GMT) Outperform A$16.33 Valuation - Sum of Parts A$ 16.77 12-month target A$ 16.50 12-month TSR % +3.9 Volatility Index Low/Medium GICS sector Commercial &
More informationEQUITY RESEARCH. OSFI releases draft of revisions to B-20 mortgage guidelines. For Required Non-U.S. Analyst and Conflicts Disclosures, see page 3.
EQUITY RESEARCH July 7, 2017 Canadian Mortgage Industry OSFI releases draft of revisions to B-20 mortgage guidelines RBC Global Equity Team Click here for contributing analysts' contact information OSFI
More informationEclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.
AUSTRALIA ECX AU Price (at 02:49, 15 Dec 2016 GMT) Outperform A$3.77 Valuation - PER A$ 3.53-3.78 12-month target A$ 4.22 12-month TSR % +16.3 Volatility Index Low/Medium GICS sector Diversified Financials
More informationSims Metal Management
AUSTRALIA SGM AU Price (at 5:11, 17 Nov 215 GMT) Outperform A$7.19 Valuation - EV/EBIT A$ 8.49-9.6 12-month target A$ 8.9 12-month TSR % +26.6 Volatility Index Medium GICS sector Materials Market cap A$m
More information3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%)
European Equity Research ACCIONA Facing a Good 2017E Spain Electricity November 7, 2016 (07:15 CET) BUY CURRENT PRICE: 69.01 TARGET PRICE: 82.40 ANA released 9M16 results on Nov 4 and we have adjusted
More informationGeneration Healthcare REIT
AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap
More informationMOD Resources Limited
Base Metals - Developer/Explorer Larry Hill Analyst Canaccord Genuity (Australia) Ltd. larry.hill@canaccord.com.au +61.2.9263.2745 22 January 2019 SPECULATIVE BUY unchanged PRICE TARGET from A$0.90 Price
More informationResetting expectations
Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp
More informationSpecial Edition Picture of the Week #2: Assessing Exposure to Brexit and Domestic Opportunities 19% 15% 4% 2% OC AWI DOOR MHK MAS WHR
EQUITY RESEARCH June 24, 2016 Homebuilders & Building Products RBC Capital Markets, LLC Robert Wetenhall (Analyst) (212) 618-3251 robert.wetenhall@rbccm.com Michael Eisen (Associate) (212) 905-5831 michael.eisen@rbccm.com
More informationSouthern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA
AUSTRALIA SXL AU Price (at 05:10, 27 Mar 2017 GMT) Neutral A$1.37 Valuation A$ - DCF (WACC 8.0%, beta 1.2, ERP 5.0%, RFR 3.3%) 1.39 12-month target A$ 1.30 12-month TSR % +0.8 Volatility Index Medium GICS
More informationEarnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation
AUSTRALIA CBA AU Price (at 06:10, 10 Sep 2013 GMT) Neutral A$73.63 Valuation A$ - DCF (WACC 10.3%, beta 1.0, ERP 5.0%, RFR 5.5%) 50.40 12-month target A$ 66.15 12-month TSR % -5.0 Volatility Index Low
More informationQ4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy
23-Apr-14 14-May-14 4-Jun-14 25-Jun-14 16-Jul-14 6-Aug-14 27-Aug-14 17-Sep-14 8-Oct-14 29-Oct-14 19-Nov-14 10-Dec-14 31-Dec-14 21-Jan-15 11-Feb-15 4-Mar-15 25-Mar-15 15-Apr-15 Daily Volume ('000) Share
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy
Equity Research Information Technology Mar 29, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$24.7 Strong earnings recovery ahead amid continued revenue momentum; maintain Buy FY1 results in
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Buy (maintained) Target price: HK$18.50 Strong FY14 results; order book momentum maintained FY14 results above expectation Net profit jumped
More informationUS Economics. RBC Capital Markets, LLC Jacob Oubina Director, Senior US Economist (212) ; ECONOMICS I RESEARCH
ECONOMICS I RESEARCH US Economics October 2015, LLC Jacob Oubina Director, Senior US Economist (212) 618-7795; jacob.oubina@rbccm.com For Required Conflicts Disclosures, please see the back of this document.
More informationRamsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst
AUSTRALIA RHC AU Price (at 06:11, 06 Aug 2015 GMT) Neutral A$66.37 Valuation A$ 64.54 - DCF (WACC 8.1%, beta 1.1, ERP 5.0%, RFR 3.8%, TGR 3.0%) 12-month target A$ 70.00 12-month TSR % +7.3 Volatility Index
More informationAutomotive Holdings Group
AUSTRALIA AHG AU Price (at 06:14, 11 Aug 2016 GMT) Outperform A$4.61 Valuation - EV/EBITA A$ 4.09-4.63 12-month target A$ 4.36 12-month TSR % -0.2 Volatility Index Low GICS sector Retailing Market cap
More informationFisher & Paykel Healthcare
NEW ZEALAND FPH NZ Price (at 05:00, 10 Jul 2015 GMT) Outperform NZ$7.03 Valuation NZ$ 7.39 - DCF (WACC 8.8%, beta 0.9, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 7.80 12-month TSR % +13.1 Volatility
More informationDetour Gold Corporation (DGC-T)
Detour Gold Corporation (DGC-T) Q2 Results Advancing Towards Full Production August 6, 2014 Michael Curran, CFA (416) 507-3950 mcurran@beaconsecurities.ca Detour Gold s focus is the continuing ramp up
More informationTox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA TOX AU Price (at 05:10, 30 Nov 2016 GMT) Outperform A$2.34 Valuation - EV/EBITDA A$ 2.52-3.07 12-month target A$ 2.79 12-month TSR % +23.1 Volatility Index Medium GICS sector Commercial & Professional
More informationAir France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview
Equity Research Quick Bite Preview 22 October 2013 Air France-KLM Q3 due 31 October More restructuring needed Supported by lower fuel costs and the ramp up in cost savings, we expect Q3 to deliver a solid
More informationHOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance
RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and
More informationTVS Motors. Source: Company Data; PL Research
Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709
More informationMaruti Suzuki. Source: Company Data; PL Research
Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty
More informationJunior Mining Review
TriAngle G4S Junior Mining Review Canadian Equity Research 13 November 2015 J. Mazumdar, Canaccord Genuity Corp. (Canada) 604-643-0272 Lee Edwards, CFA, Canaccord Genuity Corp. (Canada) 604-643-7785 Gold
More informationConsolidated Operations Group (COG)
Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation
More informationThink Childcare Limited. Delivering as promised
Childcare Australian Equity Research 21 March 2016 BUY PRICE TARGET Price (18-Mar) Ticker A$1.56 A$1.25 TNK-ASX 52-Week Range (A$): 0.77-1.27 Avg Daily Vol (M) : 0.02 Dividend /Shr (AUc): 7.2 Dividend
More informationKDDL (KDDL IN) In expansion mode
INSTITUTIONAL EQUITY RESEARCH KDDL (KDDL IN) In expansion mode INDIA MIDCAP Quarterly Update Top takeaways from 2QFY19 Results in line, recovery in manufacturing & strong growth in precision engineering.
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Buy (maintained) Target price: HK$18.50 Product mix improvement in 4Q15 order book 4Q15 order book kept at low-teen, better product mix Order
More informationDetour Gold Corporation (DGC-T)
Detour Gold Corporation (DGC-T) 2014 Financial Results Roughly In Line March 10, 2015 Michael Curran, CFA (416) 507-3950 mcurran@beaconsecurities.ca Detour Gold s focus is the continuing ramp up of its
More informationAust. General Insurance
AUSTRALIA June 2016 3 mth rolling market results Personal Commercial Market Average Rate Growth -3. -3.6% -3.3% GWP Growth 1.8% -0.8% 0.9% Volume Growth 2.8% 0.8% 2.1% Est. Exposure Value Growth 2. 2.
More informationGenworth Mortgage Insurance Australia
AUSTRALIA GMA AU Price (at 07:29, 05 Aug 2015 GMT) Outperform A$3.50 Valuation A$ - DCF (WACC 12.0%, beta 1.6, ERP 5.0%, RFR 4.5%) 3.52 12-month target A$ 3.47 12-month TSR % +9.2 Volatility Index Medium
More informationChina TCM (570 HK) Buy (maintained) Target price: HK$ H17 earnings beat, 2017 growth guidance reaffirmed; TP raised to HK$5.
Oct-14 Dec-14 Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Equity Research Healthcare China TCM (570 HK) Buy (maintained) Target price: HK$5.40
More informationBritannia Industries
Sustains momentum; Input cost gains peaked out November 09, 2015 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate Price
More informationNanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research
LINWAR Securities 30 August 2011 Nanosonics Limited Australia Health Care Equipment & Supplies Outperform (Unchanged) Price: Target Price: Stock's expected return (12mth) $0.57 $1.20 Capital growth 112.4%
More informationInsurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates
11 May 2018 RECOMMENDATIONS AUB Group (AUB) Rating HOLD Risk Low Price Target $14.50 Share Price $14.17 Steadfast Group (SDF) Rating HOLD Risk Low Price Target $2.80 Share Price $2.88 RESEARCH ANALYST
More informationBendigo and Adelaide Bank
AUSTRALIA AU Price (at 06:17, 30 Mar 2017 GMT) Underperform A$12.03 Valuation A$ 11.48- - Sum of Parts/GG 11.71 12-month target A$ 11.50 12-month TSR % +1.2 Volatility Index Low/Medium GICS sector Banks
More informationMeridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
NEW ZEALAND MEL NZ Price (at 05:00, 13 Jul 2015 GMT) Outperform NZ$2.08 Valuation NZ$ 2.50 - DCF (WACC 7.8%, beta 0.6, ERP 7.0%, RFR 3.6%, TGR 2.0%) 12-month target NZ$ 2.60 12-month TSR % +31.7 Volatility
More informationAsset revaluation driven by almonds
Company update 20 July 2015 RURAL FUNDS GROUP (RFF) Asset revaluation driven by almonds We retain a BUY rating with a 12-month target of $1.15 p/unit. RFF is a listed property trust with a portfolio of
More informationAmazon.com, Inc. (AMZN)
September 7, 2017 (AMZN) Channel Checks Highlight Positive Impact of WFM Price Cuts INVESTMENT HIGHLIGHTS: We recently conducted price comparison checks at Whole Foods, Safeway, Trader Joe's and Costco,
More informationMahindra & Mahindra. Source: Company Data; PL Research
Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty
More informationMphasis. Increased confidence on margins. Source: Company Data; PL Research
Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as
More informationBUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights
JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due
More informationChallenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation
1H13E 2H13E 1H14E 2H14E 1H15E 2H15E AUSTRALIA CGF AU Price (at CLOSE#, 20 Aug 2012) Outperform A$3.76 Volatility index Low 12-month target A$ 4.57 12-month TSR % +26.4 Valuation - Sum of Parts A$ 4.57
More informationBUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E
RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined
More informationMNF Group Limited (MNF)
MNF Group Limited (MNF) 16 February 2018 Outperform 1H18 Results: Excessive Sell-off Presents Buying Opportunity $5.14 Chris Reindler creindler@taylorcollison.com.au +61 2 9210 1335 Summary (AUD) Market
More informationSiemens. Railways and T&D driving inflows. Source: Company Data; PL Research
Railways and T&D driving inflows November 23, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,055 Target Price Rs1,230
More informationSpotless Group Holdings
AUSTRALIA SPO AU Price (at 05:45, 31 Jan 2017 GMT) Neutral A$0.94 Valuation - Peer multiples A$ 1.02 12-month target A$ 1.02 12-month TSR % +18.3 Volatility Index High GICS sector Commercial & Professional
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Hold (downgraded) Target price: HK$22.80 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong)
More informationGoodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary
Equity Research Consumer Discretionary Goodbaby (1086 HK) Buy (maintained) Target price: HK$4.20 1H16 results miss, but margin expansion continues Maintain Buy Net profit rose 21% YoY to HK$107m in 1H16,
More informationManulife Financial Corp.
I N S T I T U T I O N A L E Q U I T Y R E S E A R C H Robert Sedran, CFA 1 (416) 594-7874 Robert.Sedran@cibc.com Koki Akala, CFA 1 (416) 956-3723 Koki.Akala@cibc.com Maurissa Bell, CPA, CA 1 (416) 594-7283
More informationDollarama Inc. Q2 F2017 Preview. (1) Growth expected to continue (2) A deeper look at valuation HIGHLIGHTS. The NBF Daily Bulletin.
DOL (T) $97.04 Stock Rating: Outperform (Unchanged) Target: $105.00 (Was $104.00) Risk Rating: Average (Unchanged) Est. Total Return: 8.6% Stock Data: 52-week High-Low (Canada) Bloomberg $98.94 - $66.32
More informationAMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation
AUSTRALIA AU Price (at CLOSE#, 19 Mar 213) Underperform A$5.7 Volatility index Low 12-month target A$ 4.99 12-month TSR % +3.6 Valuation - Sum of Parts A$ 4.68 GICS sector Insurance Market cap A$m 14,855
More informationNuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision.
NEW ZEALAND NPX NZ Price (at 05:00, 31 Jul 2015 GMT) Outperform NZ$4.55 Valuation NZ$ 4.40 - DCF (WACC 12.5%, beta 1.4, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 4.75 12-month TSR % +10.6 Volatility
More informationConsolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE
Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in
More informationMiFID II Research Rules Sellside Perspective
MiFID II Research Rules Sellside Perspective Christoph Rieger Head of Rates & Credit Research +49 69 136 87664 christoph.rieger@commerzbank.com Name of speaker Department Place/dd.mm.yyyy CM-R7 ECB BMCG
More informationKingsgate Consolidated
AUSTRALIA KCN AU Price (at 6:11, 31 Jul 215 GMT) Underperform A$.67 Valuation A$ - DCF (WACC 12.%, beta 1.6, ERP 5.%, RFR 3.8%).3 12-month target A$.3 12-month TSR % -54.9 Volatility Index Very High GICS
More informationLuk Fook (590 HK) Hold Target price: HK$ Downgrade to Hold on more challenging HK & Macau market outlook. Equity Research Consumer Discretionary
Equity Research Consumer Discretionary Luk Fook (590 HK) Hold Target price: HK$24.60 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong) Brokerage Limited
More informationOil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA OSH AU Price (at 05:10, 16 Feb 2017 GMT) Outperform A$7.11 Valuation A$ - DCF (WACC 8.5%, beta 1.4, ERP 5.0%, RFR 3.3%) 6.70 12-month target A$ 7.60 12-month TSR % +8.2 Volatility Index Medium
More informationPICC Group (1339 HK)
Equity Research Financials PICC Group (1339 HK) Accumulate (Maintained) Target price: HK$4.40 Company undervalued; maintain Accumulate Positive signs for both the P&C sector in China and PICC P&C We see
More informationHaitong Securities [6837.HK]
July 14, 2015 Haitong Securities [6837.HK] Solid 1H Result Provides Buffer; Margin Financing Risk Manageable We believe a 36% correction of Haitong Securities (HTS) share price since early June has been
More informationSTMicroelectronics N.V.
ENN Europe France Semiconductors 11 Aug 2004 Deutsche Bank STMicroelectronics N.V. Reiterate cautious industry stance and lowering price target Recommendation Buy Price at 11 Aug 2004 EUR 13.94 Target
More informationFisher & Paykel Healthcare
NEW ZEALAND FPH NZ Price (at 03:59, 16 Mar 2015 GMT) Outperform NZ$6.63 Valuation NZ$ 6.86 - DCF (WACC 8.8%, beta 0.9, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 7.25 12-month TSR % +11.6 Volatility
More informationAdvanced Vision Techn Buy
16/9/13 16/11/13 16/1/14 16/3/14 16/5/14 16/7/14 16/9/14 16/11/14 16/1/15 16/3/15 16/5/15 16/7/15 MATELAN Research Update Note Closing price as of 13/8/15: 9.16 14 August 215 Company / Sector Fair Value
More informationDarden Restaurants, Inc.
Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because
More informationWhitehaven Coal. China outlook drives impairments A$1.04 AUSTRALIA. Event. Impact. Earnings and target price revision.
AUSTRALIA WHC AU Price (at 06:10, 13 Aug 2015 GMT) Neutral A$1.04 Valuation A$ - DCF (WACC 8.0%, beta 1.6, ERP 5.0%, RFR 3.8%) 1.18 12-month target A$ 1.15 12-month TSR % +10.6 Volatility Index High GICS
More informationSilicon Works (108320)
Company Note June 8, 2018 12M rating BUY (Maintain) OLED growth starts with Silicon Works 12M TP W56,000 Up/downside +38% from W56,000 2Q18 OP to surge 165% YoY to W8.4bn Despite disappointing 1Q18 results,
More informationBharat Petroleum Corporation
Higher inventory loss drag earnings August 14, 2017 Avishek Datta avishekdatta@plindia.com +91 22 66322254 Rating BUY Price Rs479 Target Price Rs553 Implied Upside 15.4% Sensex 31,449 Nifty 9,794 (Prices
More information